Haemonetics vs Merit Medical Systems
Haemonetics and Merit Medical Systems are similar in size: $1.33bn and $1.52bn of revenue in their latest fiscal years. Merit Medical Systems grew faster (11.8% against -2.0%). Merit Medical Systems kept more of each dollar of sales as profit: a net margin of 8.5% against 7.3%. Merit Medical Systems carries less debt relative to equity (47.2% against 155.7%).
| Latest fiscal year | HaemoneticsHAE, 2026 | Merit Medical SystemsMMSI, 2025 |
|---|---|---|
| Revenue | $1.33bn | $1.52bn |
| Revenue growth | -2.0% | 11.8% |
| Net income | $97.3m | $128m |
| Operating margin | 11.7% | 12.2% |
| Net margin | 7.3% | 8.5% |
| Return on equity | 12.0% | 8.7% |
| Free cash flow | $260m | $216m |
| Cash | $245m | $446m |
| Total debt | $1.24bn | $748m |
| Debt to equity | 155.7% | 47.2% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $175m | — |
| Employees | — | 7,500 |
| Market value | $5.49bn | $5.05bn |
| Price vs our value range | Above our value range | Within our value range |
| Moat score | 62 (Moderate) | 47 (Moderate) |
| Insider trades, 12 months | 1 buys, 0 sales | 5 buys, 8 sales |